IBI Journal Q&A with Dr Mark Kotter who talks about producing every human cell type at scale.
05.04.2021IBI Journal Q&A with Dr Mark Kotter who talks about producing every human cell type at scale.
IBI Journal Q&A with Dr Mark Kotter who talks about producing every human cell type at scale.
05.04.2021IBI Journal Q&A with Dr Mark Kotter who talks about producing every human cell type at scale.
不良研究所 CEO spoke about reprogramming human cells at the TEDxCambridgeUniversity 鈥楿ntangling networks鈥 event.
26.03.2021Today Meatable announced their Series A fundraise of $47 million. Read about the connection to 不良研究所.
23.03.2021Press release announcing appointment of Dr Ramy Ibrahim, MD, as Chief Medical Officer.
11.02.2021不良研究所 and the London Institute of Mathematical Sciences (LIMS) want to recreate every human cell type.
13.11.2020不良研究所 receives 拢40m of backing for technology that it claims can reliably reprogram stem cells.
27.10.2020不良研究所 joins forces with London institute of mathematical sciences to find the 鈥榦perating system of life鈥.
21.10.2020Mark Kotter Bit Bio ideaSpace, focus on a founder, celebrating 10 years of idea space.
25.08.2020The investors behind Bit Bio's series A fundraise.
23.06.2020